Tristan Penson

Intratumoral heterogeneity and <i>TERT</i> promoter mutations in progressive/higher-grade meningiomas

Tareq A. Juratli, Christian Thiede, Mara V.A. Koerner et al. · Oncotarget · 2017 · 121 citations · Full text

Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups

Tareq A. Juratli, Shilpa S. Tummala, Angelika Riedl et al. · Journal of Neuro-Oncology · 2018 · 107 citations · Full text

Neuro-oncology, Nuclear Medicine, Engineering +14

The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in <i>PIK3CA</i> -Mutant Breast Cancer Brain Metastases

Franziska M. Ippen, Christopher Alvarez‐Breckenridge, Benjamin M. Kuter et al. · Clinical Cancer Research · 2019 · 82 citations · Full text

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome

Tareq A. Juratli, Devin McCabe, Naema Nayyar et al. · Acta Neuropathologica · 2018 · 80 citations

Mendelian Disorder, Poor Outcome, Dmd Genomic Deletions +6

Genotype-targeted local therapy of glioma

Ganesh M. Shankar, Ameya R. Kirtane, Julie J. Miller et al. · Proceedings of the National Academy of Sciences · 2018 · 53 citations · Full text